STEATONIL tablet
18150 Ft
Steatonil tablet is recommended for complementary treatment of hepatitis, fatty liver, hypercholesterinemia, hypertriglyceridemia and gall bladder disorders.
Data of treatment of pregnant animals are not available, no restrictions known during lactation. Side effects are unknown.
Dosage and administration: Dog: ≤ 10kg: 3 x ¼; 10-20kg: 3 x ½; 20-30kg: 3 x ¾; ≥30kg: 3 x 1; Cat: ≤ 5kg: 3 x ¼; ≥5kg: 3 x ½; Orally or mixed with feed, in the recommended dose.
Elfogyott
Leírás
Each tablet contains:
Active substances:
Extracts of:
| Phyllanthus nirur | 150 mg |
| Picrorhiza kurroa | 150 mg |
| Grapeseed | 150 mg |
Other ingredients
Lubricants: Ethyl cellulose, Polyvinyl pyrrolidone k30, Starch, Sodium starch glycolate Magnesium Sulphate, Talc.
Coating material: Hydroxy propyl methyl cellulose, Titanium dioxide, talc, PEG – 600, Sunset yellow (E110), Isopropyl alcohol, Methylene dichloride.
Preservatives: Methylparaben Sodium and Propylparaben Sodium
Phyllanthusniruri
The extracts of Phyllanthus niruri have been thoroughly studied and documented for their hepatoprotective activity, detoxifying ability, and ability to protect against liver cirrhosis. Phyllanthus niruri exhibited hepato-protective property against cirrhosis by normalizing R.O.S. production and regulated expression of TGF beta, Colla 1, MMP2 and TMP 1 genes. Phyllanthus niruri extract could normalize increased levels of alkaline phosphatase in case of nimesulide-induced hepatotoxicity. The histopathological analysis also confirmed the protective effect of Phyllanthus niruri in severe fibrosis. Phyllanthus niruri made a drop in lipid peroxidation, enhanced antioxidant status and thereby prevented the damage to the liver and leakage of GGT and ALP enzymes.
The administration of Phyllanthus niruri extract has caused a significant increase in the Serum glucose, calcium and inorganic phosphorous levels and reduction in the serum triglyceride level whereas the milk yield was significantly increased. Negative Rothers’s and diastix strip test also indicated significant improvement in ketosis 1.
Grape Seed Extract
Analysis of hepatic transcript profile in cows fed with grape seed extract during the transition period at one week post partum indicates that polyphenol-rich feed components are able to inhibit ER stress-induced UPR and inflammatory processes both of which are considered to contribute to liver associated diseases and to impair milk performance in dairy cows, in the liver of dairy cows during early lactation.
Plasma concentration of the positive Acute Phase Protein (APP), Bovine Hepatoglobin (HP) and Serum Amyloid-A (SAA) were decreased in cows fed with Grape Seed Extract.
Feeding of Grape Seed Extract to dairy cows from 3 weeks anti-partum to 9 weeks post-partum causes beneficial changes in mRNA concentrations of hepatic genes, such as mRNA concentration of FGF21, an indicator of metabolic and Endoplasmic Reticulum (ER) stress 2.
Picrorhiza kurroa
Picrorhiza kurroa extract has the ability to increase bile production and showed a significant hypocholesterolemic effect and can, therefore, increase the HDL-level and reduce the triglyceride level significantly.
The elevation of transaminase reflects the necrosis of hepatocytes. ALT (Alanine Amino Transferase) in particular is the more specific index of hepatic necrosis. With a high-fat diet, Picrorhiza kurroa was more effective in bringing down ALT to a normal level.
Picrorhiza kurroa inhibits inflammatory TNF-receptor 1 and cyclooxygenase-2 in peritoneal macrophages. Treatment with Picrorhiza kurroa significantly inhibits iNOS and suppresses the activation of NF-kB through inhibition of its phosphorylation macrophages.
Steatonil prevents fat deposits on hepatocytes, protects hepatocytes from mitochondrial damage and improves feed intake and milk production.
It can effectively reduce ketosis and a negative energy balance during the transition phase – before and after parturition.
Registration number: 1710/1/NM/2020 NÉBIH ÁTI (60 tabl)
- Gessner et al. BMC Genomics (2017) 18:253.
- Verma PC, Basu V et al Curr Pharm Biotechnol 2009, Sept.
- Montecchio GP. et al: Centella Asiatica Triterpenic Farction (CATTF) Reducing the Number of Circulating Endothelial Cells in Subjects with Postphlebitic Syndrome. 1991;76(3);256-9
- Cesarone MR. et al: Attivita Microcirculatoria della Centella Asiatica nell’Insufficienza Venosa. Minerva cardioangiol. 1994; 42(6) 299-304. (in italian, with english summary)
- Srimal, R.C., Dhawan, BN: Pharmacology of Deiferuloyl Methane (curcumin), a Non-Steroidal Anti-Inflammatory Agent. Pharm.Pharmacol. 1973; 25: 447-52.
- Ghatak, N., Basu, N: Sodium Curcuminate as and Effective Anti-Inflammatory Agent. Indian J. Exp. Biol. 1974; 10: 235. (short communication)
- Srimal, R.C., Dhawan, B.N: Pharmacological and clinical studies on Curcuma longa. 131-42
- Deodhar, S.D. et al: Preliminary Study on Antireumatic Activity of Curcumin (Deiferuloyl Methane). Indian J. Med. Res. 1980; 71: 632-634.
- Huang, M.T. et al : Inhibitory Effects of Curcumin on in vitro Lipoxygenase and Cyclooxygenase Activities in Mouse Epidermis. Cancer Res. 1991,51,813-9.
- Rao, C.V. et al: Inhibition by Dietary Curcumin of Azoxymethane-Induced Ornithine Decarboxylase, Tyrosine Protein Kinase Arachidonic Acid Metabolism and Aberrant Crypt Formation in the Rat Colon. Carcinogenesis, 1993; 14: 2219-25.
- Rao, C.V. et al: (1993) Chemoprevention of Colon Carcinogenesis by Dietary Curcumin, a Naturally Occurring Plant Phenolic Compound Cancer Res. 55,259-266
- Sharma, S.C. et al: Lipid Peroxide Formation in Experimental Inflammation. Pharmacol. 1972; 21: 1210-1214.
- Sharma, O.P. (1976). Antioxidant activity of curcumin and related compounds Pharmacol. 25,1811-1812.





Értékelések
Még nincsenek értékelések.